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MAINE DRUG DEATH REPORT FOR 2020
Marcella H. Sorg, PhD
Margaret Chase Smith Policy Center
University of Maine
This report, funded by the Maine Office of Attorney General, provides a summary of statistics 
regarding drug fatalities in Maine during 2020. Data for the report were collected at the Office 
of Chief Medical Examiner. A drug death is identified when one or more drugs are mentioned on 
the death certificate as a cause or significant contributing factor for the death. All drug deaths 
that occurred in Maine are included, whether or not they were Maine residents. Deaths of Maine 
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Executive Summary
Drug deaths totaled 504 in 2020, a 33% increase over 380 in 2019. Of those 504, 83% were caused 
by opioids, nearly always in combination with other drugs or alcohol. This rise over 2019 was 
largely driven by a 33% rise in deaths due to nonpharmaceutical drugs, primarily fentanyl, 
increasingly combined with methamphetamine or cocaine. Because fentanyl is nearly always 
combined with other drug categories, such as pharmaceutical opioids, benzodiazepines, and 
alcohol, as well as illicit stimulants, the fentanyl increase is associated with an increase in 
those categories as well. Deaths due to nonpharmaceutical fentanyl with or without other co-
intoxicants, increased 30% from 259 to 336.
Figure 1 highlights changes in the major categories of nonpharmaceutical opioid versus 
pharmaceutical opioid deaths. The nonpharmaceutical opioid category includes fentanyl (97%) 
and its analogs, as well as heroin (11%). Heroin is involved mostly in combination with fentanyl. 
As can be seen in Figure 1, the nonpharmaceutical opioid category constitutes the majority 
(69%) of drug deaths. Pharmaceutical opioids, on the other hand, are named as a cause of death 
in 118 (23%) of deaths in 2020, an increase of 23% from 96 deaths in 2019. This category includes 
a minority of cases where there was a current prescription (19%) as well as those without a 
prescription (81%). Of those 118 pharmaceutical opioid cases, the overwhelming majority (82%) 
also included fentanyl as a co-intoxicant cause of death. 
Maine has also seen a dramatic increase in the involvement of non-opioid, illicit stimulant 
drugs, frequently combined with fentanyl. These include cocaine, which increased 7% from 
110 in 2019 to 118 in 2020, and methamphetamine, which increased 111% from 47 to 99. These 
drugs are frequently combined with nonpharmaceutical opioids. Cocaine was a co-intoxicant 
cause of death in 29% 
of fentanyl deaths and 
methamphetamine was 
a co-intoxicant cause of 
death in 21% of fentanyl 
deaths. 
Nearly all counties in 
Maine experienced 
substantial increases in 
the number of deaths, 
with the exception of 
Cumberland, Lincoln 
and Somerset, which saw 
decreases (Tables 6 and 
7). Most of these increases 
were proportionate to the 
county’s share of the drug 
deaths in 2019, rising or 
decreasing by 1% in 2020. 
Figure 1. Comparison of pharmaceutical opioid (Pharm Op) and 
nonpharmaceutical opioid (Nonpharm Op) trends, alone and in 
combination.
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However, Cumberland saw a larger decrease in its proportion of drug deaths, down by 7%. And 
Penobscot, by contrast, saw a 5% increase. It is important to note that fluctuations up and down 
within small populations are to be expected statistically. Nevertheless, these deaths will have a 
troubling impact on the communities in which they occurred.
The COVID-19 pandemic is associated in time with an increase in drug deaths during 2020. 
However, as shown in both Figures 1 and 2, the increase in deaths began in 2019, prior to the 
start of the pandemic. Figure 2 displays the quarterly trend lines for key drug categories. It 
groups all deaths in which fentanyl was a cause of death, and contrasts that total with the 
number of deaths due to other categories, without fentanyl. Fentanyl involvement is clearly 
driving much of the increase both before and during the pandemic. 
The increase in drug deaths is not due to the COVID-19 infection itself (Table 4). Only 22 cases 
out of 504 had symptoms or circumstances that prompted testing, and only one person out of 
the 22 was positive. 
Nor is the increase 
due to an increase in 
suicidal overdoses; 
that number declined 
from 34 in 2019 to 
33 in 2020, while 
accidental overdoses 
rose from 341 to 457. 
It is also not due 
to an increase in a 
particular age category 
or gender. We are 
doing more research 
to explore whether 
characteristics of 
the pandemic, such 
as isolation, access 
to medical services, 
or to alterations in 
opioid availability 
with associated 
fluctuations in opioid 
tolerance may have 
differentially exposed 
people more to the 
lethal effects of illicit 
fentanyl compared to 
other drug less lethal 
categories.
Figure 2. Comparison of drug deaths with and without nonpharmaceutical 
fentanyl mentioned as a cause of death, by annual quarter. The current 
increase in drug-induced deaths began in 2019 and was predominantly 
among deaths involving nonpharmaceutical fentanyl, and not cases caused 
by other drug categories without co-intoxicant fentanyl present.
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Overview Statistics
Manners of death
• Of the 504 drug deaths, 457 (91%) were accidental overdoses, 33 (6%) were suicidal 
overdoses, and 14 (3%) were certified as undetermined manner of death. 
Drug patterns of note in 2020 compared to 2019
• The average cause of death involved three drugs.
• Most deaths (407, 81%) were caused by two or more drugs. This is a 26% increase over 
2019 (323, 85%), and slightly less in percentage. 
• Deaths caused by opioids totaled 417 (83%), a 31% increase in number compared to 
2019 (318, 84%), but about the same proportion.
• Deaths caused by nonpharmaceutical opioids such as illicit fentanyl and heroin totaled 
346 (69% of all deaths and 83% of opioid deaths), a 29% increase in number compared 
to 2019 levels (268, 70% of all deaths and 84% of opioid deaths), but about the same 
proportion. 
• Deaths caused by pharmaceutical opioids totaled 118 (23% of all drug deaths and 28% 
of opioid deaths), a 23% increase in number compared to 2019 (96, 25% of all drug 
deaths and 30% of opioid deaths), but about the same proportion.
• Deaths caused by pharmaceutical benzodiazepines totaled 84 (17%), the same number 
as in 2019 84 (22%), but 5% lower in proportion. 
• Fentanyl and its analogs caused 336 deaths (67% of all drug deaths and 81% of opioid 
deaths), a 30% increase in number compared to 2019 (259, 68% of all drug deaths and 
81% of opioid deaths), but about the same proportion.
• Heroin caused 57 deaths (11% of all drug deaths and 18% of opioid deaths), slightly 
fewer in number and proportion of all drug deaths and about the same proportion of 
opioid deaths as in 2019 (61, 16% of all drug deaths and 19% of opioid deaths). 
• Cocaine-involved deaths totaled 118 (23% of drug deaths), a 7% increase in number 
compared to 2019 (110, 29% of drug deaths), but a lower proportion. Cocaine is a co-
intoxicant in 29% of fentanyl deaths and 30% of heroin deaths.
• Methamphetamine-involved deaths totaled 99 (20% of all deaths), a 111% increase in 
number compared to 2019 (47, 12% of all deaths), and an 8% increase in percentage.
• Deaths in Penobscot County totaled 94 (19% of state total), an increase of 77% in 
number compared to 2019 (53, 14% of state total). In Bangor specifically, deaths totaled  
57 (11% of state total) in 2020, increasing from 28 (7% of state total) in 2019. Deaths in 
Cumberland County plateaued in number and decreased in proportion in 2020 (97, 
19% of state total) compared to 2019 (100, 26% of state total). The same trend occurred 
in Portland with deaths totaling 56 (11% of state total) in 2020, compared to 55 (14% of 
state total) in 2019. 
• Of the 504 total drug deaths, 475 (94%) occurred in decedents who were described on 
the death certificate as white, 16 (3%) were Black or African American, and 10 (2%) were 
American Indian or Alaska Native. In comparison to the Maine census population, 
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the proportion of white is slightly less (94% versus 97%), Black or African American is 
slightly greater (3% versus 2%) and American Indian or Alaska Native is similar (2% 
versus 2%). The proportion of drug deaths for all other race and ethnicity categories is 
less than or similar to the census population. These proportional comparisons should 
be interpreted with caution due to the small population numbers. 
Population characteristics





range 18–24 25–39 40–59 60+ Male
All drug 
deaths
504 43 0–96  30  (6%)  183  (36%)  235  (47%)  54  (11%)  357  (71%)
Accidents 457 42 16–96  29  (6%)  176  (39%)  213  (47%)  38  (8%)  331  (72%)
Suicides 33 53 22–82  1  (3%)  6  (18%)  16  (48%)  10  (30%)   18  (55%)
1 Undetermined manner cases (n = 14) are not included in demographic analysis.






















504 475 (94%)  16  (3%)  10  (2%)  < 5  < 5  < 5  7  (1%)
Accidents 457 431 (94%)  16  (4%) see note 5     0  < 5  < 5  7  (2%)
Suicides 33 30 (91%) 0 see note 5  < 5    0     0  0
1 Undetermined manner cases (n = 14) are not included in demographic analysis.
2 Category titles are in accordance with U.S. Census Bureau and U.S. Office of Management and Budget guidelines.
3 Race categories include single race alone or in combination with one or more other categories. Therefore, the sum of all 
categories may exceed the total.
4 Values of five or fewer are suppressed to protect privacy. 
5 Accidents and suicides cannot be disaggregated for American Indian or Alaska Native due to small number of cases for 
each manner. 
Table 3.  Persons experiencing homelessness among drug deaths, 2020
Total
Persons Experiencing   
Homelessness
All drug deaths 504 36 (7%)
Table 4.  COVID-19 testing patterns among drug deaths, 2020
Total COVID-19 Tested COVID-19 Positive Test
All drug deaths 504 22 1
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Table 5.  Naloxone administration at the scene at the time of event, 2020
Total Naloxone – EMS
Naloxone –  
law enforcement
Naloxone -  
bystander
All drug deaths 504 58 13 21
1 Naloxone is a medication that can potentially reverse an opioid overdose. 
2 In some cases, naloxone was administered by more than one entity. 
3 Two additional naloxone administrations by first responders are not included in table (unknown if EMS, Law enforcement, 
or bystander).
County/city frequencies
Table 6.  Frequency of all drug deaths and opioid deaths by county and major city of death, 2020 
County 
City
Total number (%) of 
overdose deaths  
N=504
Total number (%) of 
opioid deaths  
N=417
Percentage of Maine 
census population 
(1,335,492)
Androscoggin  52  (10%)  43  (10%) 8%
Lewiston  31  (6%)  26  (6%) 3%
Aroostook  17  (3%)  14  (3%) 5%
Cumberland  97  (19%)  81  (19%) 22%
Portland  56  (11%)  45  (11%) 5%
South Portland  14  (3%)  12  (3%) 2%
Franklin  8  (2%)  8  (2%) 2%
Hancock  13  (3%)  7  (2%) 4%
Kennebec  49  (10%)  37  (9%) 9%
Augusta  18  (4%)  13  (3%) 1%
Waterville  12  (2%)  8  (2%) 1%
Knox  16  (3%)  16  (4%) 3%
Lincoln  9  (2%)  5  (1%) 3%
Oxford  15  (3%)  13  (3%) 4%
Penobscot  94  (19%)  78  (19%) 11%
Bangor  57  (11%)  48  (12%) 2%
Piscataquis  10  (2%)  7  (2%) 1%
Sagadahoc  8  (2%)  7  (2%) 3%
Somerset  13  (3%)  13  (3%) 4%
Waldo  9  (2%)  6  (1%) 3%
Washington  20  (4%)  19  (5%) 2%
York  74  (15%)  63  (15%) 15%
Biddeford  16  (3%)  15  (4%) 2%
Sanford  11  (2%)  9  (2%) 2%
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Total number (%) 
of overdose deaths  
N=504
Number (%) of  
overdose deaths,  
accident   
N=457
Percentage of Maine 
census population 
(1,335,492)
Androscoggin  52  (10%)  46  (11%) 8%
Lewiston  31  (6%)  30  (7%) 3%
Aroostook  17  (3%)  16  (4%) 5%
Cumberland  97  (19%)  88  (19%) 22%
Portland  56  (11%)  50  (11%) 5%
South Portland  14  (3%)  14  (3%) 2%
Franklin  8  (2%)  7  (2%) 2%
Hancock  13  (3%)  13  (3%) 4%
Kennebec  49  (10%)  43  (9%) 9%
Augusta  18  (4%)  15  (3%) 1%
Waterville  12  (2%)  11  (2%) 1%
Knox  16  (3%)  15  (3%) 3%
Lincoln  9  (2%)  9  (2%) 3%
Oxford  15  (3%)  14  (3%) 4%
Penobscot  94  (19%)  90  (20%) 11%
Bangor  57  (11%)  56  (12%) 2%
Piscataquis  10  (2%)  9  (2%) 1%
Sagadahoc  8  (2%)  6  (1%) 3%
Somerset  13  (3%)  13  (3%) 4%
Waldo  9  (2%)  7  (2%) 3%
Washington  20  (4%)  19  (4%) 2%
York  74  (15%)  59  (13%) 15%
Biddeford  16  (3%)  15  (3%) 2%
Sanford  11  (2%)  9  (2%) 2%
1 Undetermined manner cases (n = 14) and suicidal overdoses (n = 33) are not included in county and major city breakdown 
due to small numbers.
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Involvement of specific drug categories associated with fentanyl
Table 8.  Frequency of specific drug categories and nonpharmaceutical fentanyl involvement, 2020 
Specific drug or drug category causing the death (alone or in 
combination with other drugs and/or alcohol)
Total number  
(%) of deaths  
N=504
Number (%) within 
row involving  
nonpharmaceutical 
fentanyl
Number of deaths caused by more than one drug  407  (81%)  274  (67%)
Any pharmaceutical drug  322  (64%)  183  (57%)
Any opioid, pharmaceutical or nonpharmaceutical  417  (83%)  336  (81%)
Naloxone present in the toxicology report (see note 1)  140  (28%)  116  (83%)
Any illicitly manufactured drug  
(includes heroin/morphine, nonpharmaceutical fentanyl, 
fentanyl analogs, other illicitly-manufactured opioids, cocaine, 
methamphetamine, and MDMA)
 399  (79%)  336  (84%)
Any nonpharmaceutical opioid drugs  
(includes heroin/morphine, fentanyl, fentanyl analogs, 
U-47700, mitragynine)
 346  (69%)  336  (97%)
Fentanyl and/or fentanyl analogs  
(known pharmaceutical fentanyl removed)
 336  (67%)  336  (100%)
Heroin/morphine  
(known pharmaceutical morphine removed)
 57  (11%)  47  (82%)
Any pharmaceutical opioid  
23 (19%) of 118 had at least one current opioid prescription;  
8 (35%) of those 23 also had nonpharmaceutical fentanyl  
mentioned as a cause of their death.
Highest frequency opioids itemized below: 
Buprenorphine [12 (31%) decedents had current prescription] 
Methadone [1 (4%) decedent had current prescription] 
Oxycodone [6 (21%) decedents had current prescription]
 118  (23%)
 
 39  (8%)
 27  (5%)
 29  (6%)
 49  (42%)
 18  (46%)
 8  (30%)
 13  (45%)
Any pharmaceutical benzodiazepine   
9 (11%) of 84 had at least one current benzodiazepine  
prescription;  
3 (33%) of those 9 also had nonpharmaceutical fentanyl  
mentioned as a cause of their death
Highest frequency benzodiazepines itemized below: 
Alprazolam [5 (19%) decedents had current prescription]
Clonazepam [1 (5%) decedent had current prescription]
Diazepam [1 (8%) decedent had current prescription] 
Temazepam [2 (66%) had current prescription]
 84  (17%)
 28  (6%)
 19  (4%)
 12 (2%)
 3  (1%)
 51  (61%)
 20  (71%)
 12  (63%)
 7  (58%) 
 1  (33%)
Cocaine  118  (23%)  97  (82%)
Methamphetamine  99  (20%)  70  (71%)
Mitragynine (Kratom)  20  (4%)  11  (55%)
1 Excludes cases with buprenorphine in toxicology.
2 Cause of death can be due to multiple substances; therefore, sum of categories exceeds total drug deaths.
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Pharmaceutical Opioid Deaths
This category includes deaths caused by opioids that are manufactured by legitimate 
pharmaceutical companies and available by prescription (Figure 5). 
• Most deaths (81%) in this category involve drugs that were not currently prescribed 
to the decedent. There were 118 overdoses due to pharmaceutical opioids, alone or 
in combination with other drugs and alcohol. Of that total, 23 (19%) had a current 
prescription for the opioid that caused death, dispensed to them within 30 days of 
death. There was an additional 1 individual who had a current prescription for a 
pharmaceutical opioid, but who died due to a nonpharmaceutical opioid, and their 
prescription drug was not actually involved in the death. 
• Of the 118 deaths due to pharmaceutical opioids, almost half (50, 42%) also had a 
nonpharmaceutical opioid listed as a cause. Of the 23 that died due to a drug for which 
they had a current prescription, 9 (39%) also had a nonpharmaceutical listed as a cause 
of their death. 
• The most common pharmaceutical opioids listed as a cause of death are 
buprenorphine (39, 33% of the pharmaceutical opioid deaths), methadone (27, 23%), 
and oxycodone (29, 25%) (see Figures 6 and 7). Of the 39 decedents with buprenorphine 
listed as a cause of death, 12 had a current prescription. Of those 27 who died due to 
methadone, 1 had a current prescription. Of those 29 who died due to oxycodone, 6 had 
a current prescription. 
• Of the 118 deaths due to pharmaceutical opioids 102 (86%) were of accidental manner, 
14 (12%) were suicide and 2 (2%) are undetermined. 
Nonpharmaceutical (Illicit) Fentanyl and/or Fentanyl Analog 
Deaths
This category includes deaths caused by nonpharmaceutical (illicitly manufactured) fentanyl or 
fentanyl analogs. We removed all cases that involved known pharmaceutical fentanyl from these 
totals. 
• There were 336 overdoses due to nonpharmaceutical fentanyl and/or fentanyl analogs 
in 2020. This is a 30% increase from 259 deaths in 2019. There were 47 (14%) of the 
fentanyl and/or analog deaths combined with heroin (see Figure 8), 74 (22%) combined 
with alcohol, and 97 (29%) combined with cocaine.
• Of the 336 deaths, 331 were of accidental manner, 3 were suicide and 2 were of 
undetermined manner. 
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Table 9. Frequency of co-intoxicant drugs involved in fentanyl deaths, 2020
Specific co-intoxicants in addition to fentanyl and/or 
fentanyl analogsidentified as a cause of death
Total number (%) 
of fentanyl/ 
fentanyl  
analog deaths  
N=336
Number (%) of  
fentanyl/fentanyl  
analog deaths,  
accidental manner  
N=331
Fentanyl and fentanyl analog combinations
Fentanyl (with or without fentanyl analogs)  335  (99%)  330  (99%)
Fentanyl analogs (with or without fentanyl)  38  (11%)  36  (11%)
Both nonpharmaceutical fentanyl and at least one 
fentanyl analog
 37  (11%)  35  (11%)
Co-intoxicants identified in fentanyl and/or fentanyl analog deaths
One or more drugs (or alcohol) in addition to fentanyl 
and/or fentanyl analogs 
 272  (81%)  268  (81%)
One or more pharmaceutical opioids in addition to 
fentanyl and/or fentanyl analogs
 49  (15%)  48  (15%)
Heroin/morphine in addition to fentanyl and/or fentanyl 
analogs
 47  (14%)  47  (14%)
Alcohol in addition to fentanyl and/or fentanyl analogs  74  (22%)  71  (21%)
One or more benzodiazepines in addition to fentanyl 
and/or fentanyl analogs
 51  (15%)  51  (15%)
Cocaine in addition to fentanyl and/or fentanyl analogs  97  (29%)  96  (29%)
Methamphetamine in addition to fentanyl and/or 
fentanyl analogs
 70  (21%)  69  (21%)
1 Undetermined (n=2) and suicide (n=3) manner cases are not included in analysis. Thus, the difference 
between total (N=336) and accidental manner (n=331). 
Table 10. Frequency of fentanyl analogs identified as a cause of death, 2020
Fentanyl analog identified  
(Some cases had more than one analog)
Total number  
of cases
Percentage of  
fentanyl analog- 
involved deaths  
N=38
4-ANPP fentanyl 2 5%
Acetyl fentanyl 33 87%
Carfentanil 0 0%
Parafluoroisobutyryl fentanyl 1 3%
Valeryl fentanyl 1 3%
1 Some cases identify more than one analog as a cause of death.
2 4-ANPP, desproprionyl fentanyl was mentioned on two case death certificates, however it is generally 
categorized as a precursor of fentanyl, produced during manufacture, or as a metabolite. .
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Heroin/Morphine Deaths
Heroin/morphine deaths include any death in which the cause of death identifies “heroin” or 
“morphine.”  We have removed all cases involving known pharmaceutical morphine, so the 
heroin/morphine deaths are all probable heroin overdoses. 
• In 2020 there were 57 deaths due to (nonpharmaceutical) heroin/morphine alone or 
in combination with other drugs. This is a 7% decrease from the 61 heroin/morphine 
deaths identified in 2019.
• Of the 57 deaths, 44 (77%) were male and 13 (23%) were female. The average age of 
heroin/morphine deaths was 45 (age range 23-82). 
• 55 of 57 (97%) were ruled accidental manner of death. 
Table 11. Frequency of co-intoxicant drugs involved in heroin/morphine deaths, 2020
Specific co-intoxicants in addition to  
heroin/morphine identified on the death  
certificate as a cause of death








One or more drugs (or alcohol) in addition to heroin/morphine  56  (98%)  55  (100%)
At least one pharmaceutical opioid in addition to heroin/
morphine
 11  (19%)  11  (20%)
Nonpharmaceutical fentanyl and/or at least one fentanyl 
analog in addition to heroin/morphine
 47  (82%)  47  (85%)
Alcohol in addition to heroin/morphine  12  (21%)  12  (22%)
At least one benzodiazepine in addition to heroin/morphine  10  (18%)  9  (16%)
Cocaine in addition to heroin/morphine  17  (30%)  17  (31%)
Methamphetamine in addition to heroin/morphine  15  (26%)  15  (27%)
1 Undetermined (N=1) and suicide (N=1) manner cases are not included analysis. Thus, the difference between total (N=57) 
and accidental manner (N=55).
Deaths Involving Illicit Stimulants Cocaine and  
Methamphetamine
Deaths involving cocaine have been rising since 2014 (see Figure 4). In 2013 there were 10 
cocaine deaths. By 2014 the number had more than doubled to 24. The total has been rising 
steadily, and reached 118 in 2020, which is 23% of all drug deaths, compared to 110 (29%) of 
drug deaths in 2019. Most (97, 82%) of cocaine deaths list at least one nonpharmaceutical opioid 
as a co-intoxicant; 23 (19%) of cocaine deaths list at least one pharmaceutical opioid as a co-
intoxicant. Cocaine is a co-intoxicant in 29% of fentanyl deaths and 30% of heroin deaths. Of the 
118 deaths involving cocaine, 116 (98%) were of accidental manner and 2 (2%) were suicide. 
Deaths due to methamphetamine totaled 99, a 111% increase from 47 in 2019. As shown in 
Figure 4, these totals began rising in 2016. Most (73, 74%) of methamphetamine deaths list at 
least one nonpharmaceutical opioid as a co-intoxicant; 16 (16%) of methamphetamine deaths 
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list at least one pharmaceutical opioid as a co-intoxicant. Methamphetamine is a co-intoxicant 
in 21% of fentanyl deaths and 26% of heroin deaths. Methamphetamine is a co-intoxicant in 16 
of the 118 total (14%) cocaine deaths. Of the 99 deaths, 98 were of accidental manner and 1 is 
undetermined. 
 
Figure 3. Number of drug-induced deaths in Maine, with subtotals for deaths caused by any 
pharmaceutical drugs (alone or in combination) and for deaths caused by any nonpharmaceutical 
(illicit) drugs (alone or in combination). Most deaths were caused by more than one drug. 
Pharmaceutical and nonpharmaceutical (illicit) drugs may be combined to cause death. Note: 2017 
total was revised from 418 to 417 subsequent to the release of the 2017 report.
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Figure 4. Number of deaths caused by cocaine and by methamphetamine, alone or in combination 
with other drugs.
Figure 5. Comparison of the total number drug deaths and the total due to pharmaceutical versus 
nonpharmaceutical opioids, alone or in combination with other drugs and/or alcohol.
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Figure 6. Number of deaths caused by key pharmaceutical opioids, alone or in combination with 
other drugs. Note that fentanyl cases in this graph are pharmaceutical fentanyl.
Figure 7. Comparison of deaths due to buprenorphine combined or not combined with 
nonpharmaceutical fentanyl and/or fentanyl analogs.
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Figure 8. Total deaths due to heroin/morphine (HM) with nonpharm fent (nonpharm fent) and/or 
fentanyl analogs, alone or in combination with each other.
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